ICON - International Council on Nanotechnology: A partnership for nanotechnology stewardship and sustainability

GoodNanoGuide
Virtual Journal
ICON - International Council on Nanotechnology

Rice University
CBEN
ICON Web & News Virtual Journal Everything
  
ICON - International Council on Nanotechnology
Join Us - ICON About - ICON ICON Newsroom ICON Working Groups Projects ICON Resources Virtual Journal ICON Events International Council on Nanotechnology International Council on Nanotechnology International Council on Nanotechnology

Resources

Virtual Journal 
Analyze Database
GoodNanoGuide
ICON Reports
ICON Backgrounders
Glossary
Policy Reports

Ratings Comment
Guidelines
Links


Quick Search:

Keywords:

Search:


Search Using OECD Database
Details Return to Previous Page Addition or Correction
Title: ÉquiNanos: innovative team for nanoparticle risk management
Date: 1/2013
  Link to Journal Abstract
Abstract: Interactions between nanoparticles (NP), humans and the environment are not fully understood yet. Moreover, frameworks aiming at protecting human health have not been adapted to NP but are nonetheless applied to NP-related activities. Consequently, business organizations currently have to deal with NP-related risks despite the lack of a proven effective method of risk-management. To respond to these concerns and fulfill the needs of populations and industries, ÉquiNanos was created as a largely interdisciplinary provincial research team in Canada. ÉquiNanos consists of eight platforms with different areas of action, from adaptive decision-aid tool to public and legal governance, while including biological monitoring. ÉquiNanos resources aim at responding to the concerns of the Quebec nanotechnology industry and public health authorities. Our mandate is to understand the impact of NP on human health in order to protect the population against all potential risks emerging from these high-priority and rapidly expanding innovative technologies.
Non-technical Summary: In this paper by Canadian authors an important framework is discussed with the goal of acquiring more detailed information and establishing an infrastructure to evaluate the interaction between nanoparticles and living organisms, with the ultimate goal of safety and risk management of the rapidly growing fields of nanotechnology-based biological applications.
Content Emphasis Peer Reviewed Journal Article
Exposure Or Hazard Target Mammalian
Exposure Pathway Other/Unspecified
Method Of Study Other
Paper Type Commentaries
Particle Type Other/Unspecified
Production Method Engineered
Risk Exposure Group General Population
Target Audience Technical Research
Public Policy
Citation: Nanomedicine: Nanotechnology, Biology and Medicine, 9(1): 22-24 (January 2013)
Publication: Nanomedicine: Nanotechnology, Biology and Medicine
Author: Nadeau S, Bouchard M, Debia M, DeMarcellis-Warin N, Halle S, Songmene V, Therrien MC, Wilkinson K, Ateme-Nguema B, Dufour G, Dufresne A, Fatisson J, Haddad S, Hadioui M, Kouam J, Morency F, Tardiff R, Viens M, Weichenthal S, Viau C, Camus M
Volume: 9
Number: 1
Pages: 22-24
     


Last updated on February 12, 2013
Permalink



Join Us | About | Newsroom | Working Groups | Projects | Resources | Virtual Journal | Events | Logout

This work is supported in part by the Nanoscale Science and Engineering Initiative of the National Science Foundation
under NSF Award Number EEC-0118007.

 		 
Rice University